SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-036937
Filing Date
2024-08-13
Accepted
2024-08-13 07:50:29
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20029692_10q.htm   iXBRL 10-Q 1195190
2 EXHIBIT 31.1 ef20029692_ex31-1.htm EX-31.1 10713
3 EXHIBIT 31.2 ef20029692_ex31-2.htm EX-31.2 10756
4 EXHIBIT 32.1 ef20029692_ex32-1.htm EX-32.1 5145
5 EXHIBIT 32.2 ef20029692_ex32-2.htm EX-32.2 5059
  Complete submission text file 0001140361-24-036937.txt   5966428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20240630.xsd EX-101.SCH 44005
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20240630_cal.xml EX-101.CAL 32988
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20240630_def.xml EX-101.DEF 239951
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20240630_lab.xml EX-101.LAB 577827
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20240630_pre.xml EX-101.PRE 373950
65 EXTRACTED XBRL INSTANCE DOCUMENT ef20029692_10q_htm.xml XML 842187
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 241198808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)